'Waiting for DCGI approval': AIIMS Doctor on Covaxin trials on children
New Delhi, May 12 (ANI): Soon after Bharat Biotech's Covaxin gets nod for phase II and III trials, Delhi AIIMS Doctor for Department of Medicine Sanjeev Sinha on May 12 said that the hospital will start trials after DCGI approval. "Recently, subject expert committee of DCGI gave permission for vaccine trials on children from 2 to 15 years of age to Bharat Biotech. We are waiting for DCGI approval. Hopefully, we will soon start phase 2 and phase 3 trials," said AIIMS Doctor Sinha.